Patents by Inventor Christopher J. Monceaux

Christopher J. Monceaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibiting neurotransmitter reuptake
    Patent number: 9944618
    Abstract: This document relates to compounds as well as methods and materials involved in modulating neurotransmitter reuptake. For example, compounds, methods for synthesizing compounds, and methods for inhibiting neurotransmitter reuptake are provided. Specifically gamma-amino alcohol derivatives that inhibit the reuptake of neurotransmitters such as dopamine, serotonin, epinephrine or norepinephrine are provided as therapeutic agents for the treatment of depression or anxiety in a mammalian subject.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: April 17, 2018
    Assignees: Mayo Foundation for Medical Education and Research, Virginia Tech Intellectual Properties, Inc.
    Inventors: Elliott Richelson, Abdul H. Fauq, Paul Carlier, Christopher J. Monceaux
  • INHIBITING NEUROTRANSMITTER REUPTAKE
    Publication number: 20160024044
    Abstract: This document relates to compounds as well as methods and materials involved in modulating neurotransmitter reuptake. For example, compounds, methods for synthesizing compounds, and methods for inhibiting neurotransmitter reuptake are provided. Specifically gamma-amino alcohol derivatives that inhibit the reuptake of neurotransmitters such as dopamine, serotonin, epinephrine or norepinephrine are provided as therapeutic agents for the treatment of depression or anxiety in a mammalian subject.
    Type: Application
    Filed: March 10, 2014
    Publication date: January 28, 2016
    Inventors: Elliott Richelson, Abdul H. Fauq, Paul Carlier, Christopher J. Monceaux